Global Amebiasis Market Growth (Status and Outlook) 2025-2031

September 2025 | 106 pages | ID: GFF9E3C97906EN
LP Information

US$ 3,660.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
According to this study, the global Amebiasis market size will reach US$ 1460 million by 2031.

Amebiasis is an infection of the intestine caused by a parasite Entamoeba Histolytica. Symptoms of this disease include loose stool, abdominal cramping, and stomach pain.

The amebiasis drugs market is driven by the high burden of amebiasis infections, caused by the parasite Entamoeba histolytica, especially in developing regions with poor sanitation and healthcare facilities. Amebiasis can lead to severe gastrointestinal symptoms and potentially life-threatening complications. The increasing prevalence and severity of the disease have contributed to the demand for effective drugs to treat and manage amebiasis. Additionally, advancements in medical research and drug development have led to the introduction of new and improved therapies for better patient outcomes. However, challenges include the need for early diagnosis and proper management to prevent complications, potential drug resistance, and limited access to healthcare in some regions. Overcoming these challenges through increased awareness, affordable treatment options, and improved healthcare infrastructure will be crucial for the sustained growth of the amebiasis drugs market.

LPI (LP Information)' newest research report, the “Amebiasis Industry Forecast” looks at past sales and reviews total world Amebiasis sales in 2024, providing a comprehensive analysis by region and market sector of projected Amebiasis sales for 2025 through 2031. With Amebiasis sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Amebiasis industry.

This Insight Report provides a comprehensive analysis of the global Amebiasis landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Amebiasis portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Amebiasis market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Amebiasis and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Amebiasis.

This report presents a comprehensive overview, market shares, and growth opportunities of Amebiasis market by product type, application, key players and key regions and countries.

Segmentation by Type:
  • Metronidazole
  • Paromomycin
  • Tinidazole
  • Other
Segmentation by Application:
  • Hospital
  • Pharmacy
This report also splits the market by region:
  • Americas
    • United States
    • Canada
    • Mexico
    • Brazil
  • APAC
    • China
    • Japan
    • Korea
    • Southeast Asia
    • India
    • Australia
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
  • Middle East & Africa
    • Egypt
    • South Africa
    • Israel
    • Turkey
    • GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
  • Dr. Reddy’s Laboratories
  • Mission Pharmacal
  • Aceto Corporation
  • Mylan Pharmaceuticals
  • Impax Laboratories
  • Pfizer
  • Sanofi
  • Lupin Pharmaceuticals
  • Glenmark Pharmaceuticals
  • Sun Pharmaceutical
  • Heritage Pharmaceuticals
1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Amebiasis Market Size (2020-2031)
  2.1.2 Amebiasis Market Size CAGR by Region (2020 VS 2024 VS 2031)
  2.1.3 World Current & Future Analysis for Amebiasis by Country/Region (2020, 2024 & 2031)
2.2 Amebiasis Segment by Type
  2.2.1 Metronidazole
  2.2.2 Paromomycin
  2.2.3 Tinidazole
  2.2.4 Other
2.3 Amebiasis Market Size by Type
  2.3.1 Amebiasis Market Size CAGR by Type (2020 VS 2024 VS 2031)
  2.3.2 Global Amebiasis Market Size Market Share by Type (2020-2025)
2.4 Amebiasis Segment by Application
  2.4.1 Hospital
  2.4.2 Pharmacy
2.5 Amebiasis Market Size by Application
  2.5.1 Amebiasis Market Size CAGR by Application (2020 VS 2024 VS 2031)
  2.5.2 Global Amebiasis Market Size Market Share by Application (2020-2025)

3 AMEBIASIS MARKET SIZE BY PLAYER

3.1 Amebiasis Market Size Market Share by Player
  3.1.1 Global Amebiasis Revenue by Player (2020-2025)
  3.1.2 Global Amebiasis Revenue Market Share by Player (2020-2025)
3.2 Global Amebiasis Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 AMEBIASIS BY REGION

4.1 Amebiasis Market Size by Region (2020-2025)
4.2 Global Amebiasis Annual Revenue by Country/Region (2020-2025)
4.3 Americas Amebiasis Market Size Growth (2020-2025)
4.4 APAC Amebiasis Market Size Growth (2020-2025)
4.5 Europe Amebiasis Market Size Growth (2020-2025)
4.6 Middle East & Africa Amebiasis Market Size Growth (2020-2025)

5 AMERICAS

5.1 Americas Amebiasis Market Size by Country (2020-2025)
5.2 Americas Amebiasis Market Size by Type (2020-2025)
5.3 Americas Amebiasis Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Amebiasis Market Size by Region (2020-2025)
6.2 APAC Amebiasis Market Size by Type (2020-2025)
6.3 APAC Amebiasis Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Amebiasis Market Size by Country (2020-2025)
7.2 Europe Amebiasis Market Size by Type (2020-2025)
7.3 Europe Amebiasis Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Amebiasis by Region (2020-2025)
8.2 Middle East & Africa Amebiasis Market Size by Type (2020-2025)
8.3 Middle East & Africa Amebiasis Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL AMEBIASIS MARKET FORECAST

10.1 Global Amebiasis Forecast by Region (2026-2031)
  10.1.1 Global Amebiasis Forecast by Region (2026-2031)
  10.1.2 Americas Amebiasis Forecast
  10.1.3 APAC Amebiasis Forecast
  10.1.4 Europe Amebiasis Forecast
  10.1.5 Middle East & Africa Amebiasis Forecast
10.2 Americas Amebiasis Forecast by Country (2026-2031)
  10.2.1 United States Market Amebiasis Forecast
  10.2.2 Canada Market Amebiasis Forecast
  10.2.3 Mexico Market Amebiasis Forecast
  10.2.4 Brazil Market Amebiasis Forecast
10.3 APAC Amebiasis Forecast by Region (2026-2031)
  10.3.1 China Amebiasis Market Forecast
  10.3.2 Japan Market Amebiasis Forecast
  10.3.3 Korea Market Amebiasis Forecast
  10.3.4 Southeast Asia Market Amebiasis Forecast
  10.3.5 India Market Amebiasis Forecast
  10.3.6 Australia Market Amebiasis Forecast
10.4 Europe Amebiasis Forecast by Country (2026-2031)
  10.4.1 Germany Market Amebiasis Forecast
  10.4.2 France Market Amebiasis Forecast
  10.4.3 UK Market Amebiasis Forecast
  10.4.4 Italy Market Amebiasis Forecast
  10.4.5 Russia Market Amebiasis Forecast
10.5 Middle East & Africa Amebiasis Forecast by Region (2026-2031)
  10.5.1 Egypt Market Amebiasis Forecast
  10.5.2 South Africa Market Amebiasis Forecast
  10.5.3 Israel Market Amebiasis Forecast
  10.5.4 Turkey Market Amebiasis Forecast
10.6 Global Amebiasis Forecast by Type (2026-2031)
10.7 Global Amebiasis Forecast by Application (2026-2031)
  10.7.1 GCC Countries Market Amebiasis Forecast

11 KEY PLAYERS ANALYSIS

11.1 Dr. Reddy’s Laboratories
  11.1.1 Dr. Reddy’s Laboratories Company Information
  11.1.2 Dr. Reddy’s Laboratories Amebiasis Product Offered
  11.1.3 Dr. Reddy’s Laboratories Amebiasis Revenue, Gross Margin and Market Share (2020-2025)
  11.1.4 Dr. Reddy’s Laboratories Main Business Overview
  11.1.5 Dr. Reddy’s Laboratories Latest Developments
11.2 Mission Pharmacal
  11.2.1 Mission Pharmacal Company Information
  11.2.2 Mission Pharmacal Amebiasis Product Offered
  11.2.3 Mission Pharmacal Amebiasis Revenue, Gross Margin and Market Share (2020-2025)
  11.2.4 Mission Pharmacal Main Business Overview
  11.2.5 Mission Pharmacal Latest Developments
11.3 Aceto Corporation
  11.3.1 Aceto Corporation Company Information
  11.3.2 Aceto Corporation Amebiasis Product Offered
  11.3.3 Aceto Corporation Amebiasis Revenue, Gross Margin and Market Share (2020-2025)
  11.3.4 Aceto Corporation Main Business Overview
  11.3.5 Aceto Corporation Latest Developments
11.4 Mylan Pharmaceuticals
  11.4.1 Mylan Pharmaceuticals Company Information
  11.4.2 Mylan Pharmaceuticals Amebiasis Product Offered
  11.4.3 Mylan Pharmaceuticals Amebiasis Revenue, Gross Margin and Market Share (2020-2025)
  11.4.4 Mylan Pharmaceuticals Main Business Overview
  11.4.5 Mylan Pharmaceuticals Latest Developments
11.5 Impax Laboratories
  11.5.1 Impax Laboratories Company Information
  11.5.2 Impax Laboratories Amebiasis Product Offered
  11.5.3 Impax Laboratories Amebiasis Revenue, Gross Margin and Market Share (2020-2025)
  11.5.4 Impax Laboratories Main Business Overview
  11.5.5 Impax Laboratories Latest Developments
11.6 Pfizer
  11.6.1 Pfizer Company Information
  11.6.2 Pfizer Amebiasis Product Offered
  11.6.3 Pfizer Amebiasis Revenue, Gross Margin and Market Share (2020-2025)
  11.6.4 Pfizer Main Business Overview
  11.6.5 Pfizer Latest Developments
11.7 Sanofi
  11.7.1 Sanofi Company Information
  11.7.2 Sanofi Amebiasis Product Offered
  11.7.3 Sanofi Amebiasis Revenue, Gross Margin and Market Share (2020-2025)
  11.7.4 Sanofi Main Business Overview
  11.7.5 Sanofi Latest Developments
11.8 Lupin Pharmaceuticals
  11.8.1 Lupin Pharmaceuticals Company Information
  11.8.2 Lupin Pharmaceuticals Amebiasis Product Offered
  11.8.3 Lupin Pharmaceuticals Amebiasis Revenue, Gross Margin and Market Share (2020-2025)
  11.8.4 Lupin Pharmaceuticals Main Business Overview
  11.8.5 Lupin Pharmaceuticals Latest Developments
11.9 Glenmark Pharmaceuticals
  11.9.1 Glenmark Pharmaceuticals Company Information
  11.9.2 Glenmark Pharmaceuticals Amebiasis Product Offered
  11.9.3 Glenmark Pharmaceuticals Amebiasis Revenue, Gross Margin and Market Share (2020-2025)
  11.9.4 Glenmark Pharmaceuticals Main Business Overview
  11.9.5 Glenmark Pharmaceuticals Latest Developments
11.10 Sun Pharmaceutical
  11.10.1 Sun Pharmaceutical Company Information
  11.10.2 Sun Pharmaceutical Amebiasis Product Offered
  11.10.3 Sun Pharmaceutical Amebiasis Revenue, Gross Margin and Market Share (2020-2025)
  11.10.4 Sun Pharmaceutical Main Business Overview
  11.10.5 Sun Pharmaceutical Latest Developments
11.11 Heritage Pharmaceuticals
  11.11.1 Heritage Pharmaceuticals Company Information
  11.11.2 Heritage Pharmaceuticals Amebiasis Product Offered
  11.11.3 Heritage Pharmaceuticals Amebiasis Revenue, Gross Margin and Market Share (2020-2025)
  11.11.4 Heritage Pharmaceuticals Main Business Overview
  11.11.5 Heritage Pharmaceuticals Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

LIST OF TABLES

Table 1. Amebiasis Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Amebiasis Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Metronidazole
Table 4. Major Players of Paromomycin
Table 5. Major Players of Tinidazole
Table 6. Major Players of Other
Table 7. Amebiasis Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 8. Global Amebiasis Market Size by Type (2020-2025) & ($ millions)
Table 9. Global Amebiasis Market Size Market Share by Type (2020-2025)
Table 10. Amebiasis Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 11. Global Amebiasis Market Size by Application (2020-2025) & ($ millions)
Table 12. Global Amebiasis Market Size Market Share by Application (2020-2025)
Table 13. Global Amebiasis Revenue by Player (2020-2025) & ($ millions)
Table 14. Global Amebiasis Revenue Market Share by Player (2020-2025)
Table 15. Amebiasis Key Players Head office and Products Offered
Table 16. Amebiasis Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 17. New Products and Potential Entrants
Table 18. Mergers & Acquisitions, Expansion
Table 19. Global Amebiasis Market Size by Region (2020-2025) & ($ millions)
Table 20. Global Amebiasis Market Size Market Share by Region (2020-2025)
Table 21. Global Amebiasis Revenue by Country/Region (2020-2025) & ($ millions)
Table 22. Global Amebiasis Revenue Market Share by Country/Region (2020-2025)
Table 23. Americas Amebiasis Market Size by Country (2020-2025) & ($ millions)
Table 24. Americas Amebiasis Market Size Market Share by Country (2020-2025)
Table 25. Americas Amebiasis Market Size by Type (2020-2025) & ($ millions)
Table 26. Americas Amebiasis Market Size Market Share by Type (2020-2025)
Table 27. Americas Amebiasis Market Size by Application (2020-2025) & ($ millions)
Table 28. Americas Amebiasis Market Size Market Share by Application (2020-2025)
Table 29. APAC Amebiasis Market Size by Region (2020-2025) & ($ millions)
Table 30. APAC Amebiasis Market Size Market Share by Region (2020-2025)
Table 31. APAC Amebiasis Market Size by Type (2020-2025) & ($ millions)
Table 32. APAC Amebiasis Market Size by Application (2020-2025) & ($ millions)
Table 33. Europe Amebiasis Market Size by Country (2020-2025) & ($ millions)
Table 34. Europe Amebiasis Market Size Market Share by Country (2020-2025)
Table 35. Europe Amebiasis Market Size by Type (2020-2025) & ($ millions)
Table 36. Europe Amebiasis Market Size by Application (2020-2025) & ($ millions)
Table 37. Middle East & Africa Amebiasis Market Size by Region (2020-2025) & ($ millions)
Table 38. Middle East & Africa Amebiasis Market Size by Type (2020-2025) & ($ millions)
Table 39. Middle East & Africa Amebiasis Market Size by Application (2020-2025) & ($ millions)
Table 40. Key Market Drivers & Growth Opportunities of Amebiasis
Table 41. Key Market Challenges & Risks of Amebiasis
Table 42. Key Industry Trends of Amebiasis
Table 43. Global Amebiasis Market Size Forecast by Region (2026-2031) & ($ millions)
Table 44. Global Amebiasis Market Size Market Share Forecast by Region (2026-2031)
Table 45. Global Amebiasis Market Size Forecast by Type (2026-2031) & ($ millions)
Table 46. Global Amebiasis Market Size Forecast by Application (2026-2031) & ($ millions)
Table 47. Dr. Reddy’s Laboratories Details, Company Type, Amebiasis Area Served and Its Competitors
Table 48. Dr. Reddy’s Laboratories Amebiasis Product Offered
Table 49. Dr. Reddy’s Laboratories Amebiasis Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 50. Dr. Reddy’s Laboratories Main Business
Table 51. Dr. Reddy’s Laboratories Latest Developments
Table 52. Mission Pharmacal Details, Company Type, Amebiasis Area Served and Its Competitors
Table 53. Mission Pharmacal Amebiasis Product Offered
Table 54. Mission Pharmacal Amebiasis Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 55. Mission Pharmacal Main Business
Table 56. Mission Pharmacal Latest Developments
Table 57. Aceto Corporation Details, Company Type, Amebiasis Area Served and Its Competitors
Table 58. Aceto Corporation Amebiasis Product Offered
Table 59. Aceto Corporation Amebiasis Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 60. Aceto Corporation Main Business
Table 61. Aceto Corporation Latest Developments
Table 62. Mylan Pharmaceuticals Details, Company Type, Amebiasis Area Served and Its Competitors
Table 63. Mylan Pharmaceuticals Amebiasis Product Offered
Table 64. Mylan Pharmaceuticals Amebiasis Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 65. Mylan Pharmaceuticals Main Business
Table 66. Mylan Pharmaceuticals Latest Developments
Table 67. Impax Laboratories Details, Company Type, Amebiasis Area Served and Its Competitors
Table 68. Impax Laboratories Amebiasis Product Offered
Table 69. Impax Laboratories Amebiasis Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 70. Impax Laboratories Main Business
Table 71. Impax Laboratories Latest Developments
Table 72. Pfizer Details, Company Type, Amebiasis Area Served and Its Competitors
Table 73. Pfizer Amebiasis Product Offered
Table 74. Pfizer Amebiasis Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 75. Pfizer Main Business
Table 76. Pfizer Latest Developments
Table 77. Sanofi Details, Company Type, Amebiasis Area Served and Its Competitors
Table 78. Sanofi Amebiasis Product Offered
Table 79. Sanofi Amebiasis Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 80. Sanofi Main Business
Table 81. Sanofi Latest Developments
Table 82. Lupin Pharmaceuticals Details, Company Type, Amebiasis Area Served and Its Competitors
Table 83. Lupin Pharmaceuticals Amebiasis Product Offered
Table 84. Lupin Pharmaceuticals Amebiasis Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 85. Lupin Pharmaceuticals Main Business
Table 86. Lupin Pharmaceuticals Latest Developments
Table 87. Glenmark Pharmaceuticals Details, Company Type, Amebiasis Area Served and Its Competitors
Table 88. Glenmark Pharmaceuticals Amebiasis Product Offered
Table 89. Glenmark Pharmaceuticals Amebiasis Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 90. Glenmark Pharmaceuticals Main Business
Table 91. Glenmark Pharmaceuticals Latest Developments
Table 92. Sun Pharmaceutical Details, Company Type, Amebiasis Area Served and Its Competitors
Table 93. Sun Pharmaceutical Amebiasis Product Offered
Table 94. Sun Pharmaceutical Amebiasis Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 95. Sun Pharmaceutical Main Business
Table 96. Sun Pharmaceutical Latest Developments
Table 97. Heritage Pharmaceuticals Details, Company Type, Amebiasis Area Served and Its Competitors
Table 98. Heritage Pharmaceuticals Amebiasis Product Offered
Table 99. Heritage Pharmaceuticals Amebiasis Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 100. Heritage Pharmaceuticals Main Business
Table 101. Heritage Pharmaceuticals Latest Developments

LIST OF FIGURES

Figure 1. Amebiasis Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Amebiasis Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Amebiasis Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Amebiasis Sales Market Share by Country/Region (2024)
Figure 8. Amebiasis Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Amebiasis Market Size Market Share by Type in 2024
Figure 10. Amebiasis in Hospital
Figure 11. Global Amebiasis Market: Hospital (2020-2025) & ($ millions)
Figure 12. Amebiasis in Pharmacy
Figure 13. Global Amebiasis Market: Pharmacy (2020-2025) & ($ millions)
Figure 14. Global Amebiasis Market Size Market Share by Application in 2024
Figure 15. Global Amebiasis Revenue Market Share by Player in 2024
Figure 16. Global Amebiasis Market Size Market Share by Region (2020-2025)
Figure 17. Americas Amebiasis Market Size 2020-2025 ($ millions)
Figure 18. APAC Amebiasis Market Size 2020-2025 ($ millions)
Figure 19. Europe Amebiasis Market Size 2020-2025 ($ millions)
Figure 20. Middle East & Africa Amebiasis Market Size 2020-2025 ($ millions)
Figure 21. Americas Amebiasis Value Market Share by Country in 2024
Figure 22. United States Amebiasis Market Size Growth 2020-2025 ($ millions)
Figure 23. Canada Amebiasis Market Size Growth 2020-2025 ($ millions)
Figure 24. Mexico Amebiasis Market Size Growth 2020-2025 ($ millions)
Figure 25. Brazil Amebiasis Market Size Growth 2020-2025 ($ millions)
Figure 26. APAC Amebiasis Market Size Market Share by Region in 2024
Figure 27. APAC Amebiasis Market Size Market Share by Type (2020-2025)
Figure 28. APAC Amebiasis Market Size Market Share by Application (2020-2025)
Figure 29. China Amebiasis Market Size Growth 2020-2025 ($ millions)
Figure 30. Japan Amebiasis Market Size Growth 2020-2025 ($ millions)
Figure 31. South Korea Amebiasis Market Size Growth 2020-2025 ($ millions)
Figure 32. Southeast Asia Amebiasis Market Size Growth 2020-2025 ($ millions)
Figure 33. India Amebiasis Market Size Growth 2020-2025 ($ millions)
Figure 34. Australia Amebiasis Market Size Growth 2020-2025 ($ millions)
Figure 35. Europe Amebiasis Market Size Market Share by Country in 2024
Figure 36. Europe Amebiasis Market Size Market Share by Type (2020-2025)
Figure 37. Europe Amebiasis Market Size Market Share by Application (2020-2025)
Figure 38. Germany Amebiasis Market Size Growth 2020-2025 ($ millions)
Figure 39. France Amebiasis Market Size Growth 2020-2025 ($ millions)
Figure 40. UK Amebiasis Market Size Growth 2020-2025 ($ millions)
Figure 41. Italy Amebiasis Market Size Growth 2020-2025 ($ millions)
Figure 42. Russia Amebiasis Market Size Growth 2020-2025 ($ millions)
Figure 43. Middle East & Africa Amebiasis Market Size Market Share by Region (2020-2025)
Figure 44. Middle East & Africa Amebiasis Market Size Market Share by Type (2020-2025)
Figure 45. Middle East & Africa Amebiasis Market Size Market Share by Application (2020-2025)
Figure 46. Egypt Amebiasis Market Size Growth 2020-2025 ($ millions)
Figure 47. South Africa Amebiasis Market Size Growth 2020-2025 ($ millions)
Figure 48. Israel Amebiasis Market Size Growth 2020-2025 ($ millions)
Figure 49. Turkey Amebiasis Market Size Growth 2020-2025 ($ millions)
Figure 50. GCC Countries Amebiasis Market Size Growth 2020-2025 ($ millions)
Figure 51. Americas Amebiasis Market Size 2026-2031 ($ millions)
Figure 52. APAC Amebiasis Market Size 2026-2031 ($ millions)
Figure 53. Europe Amebiasis Market Size 2026-2031 ($ millions)
Figure 54. Middle East & Africa Amebiasis Market Size 2026-2031 ($ millions)
Figure 55. United States Amebiasis Market Size 2026-2031 ($ millions)
Figure 56. Canada Amebiasis Market Size 2026-2031 ($ millions)
Figure 57. Mexico Amebiasis Market Size 2026-2031 ($ millions)
Figure 58. Brazil Amebiasis Market Size 2026-2031 ($ millions)
Figure 59. China Amebiasis Market Size 2026-2031 ($ millions)
Figure 60. Japan Amebiasis Market Size 2026-2031 ($ millions)
Figure 61. Korea Amebiasis Market Size 2026-2031 ($ millions)
Figure 62. Southeast Asia Amebiasis Market Size 2026-2031 ($ millions)
Figure 63. India Amebiasis Market Size 2026-2031 ($ millions)
Figure 64. Australia Amebiasis Market Size 2026-2031 ($ millions)
Figure 65. Germany Amebiasis Market Size 2026-2031 ($ millions)
Figure 66. France Amebiasis Market Size 2026-2031 ($ millions)
Figure 67. UK Amebiasis Market Size 2026-2031 ($ millions)
Figure 68. Italy Amebiasis Market Size 2026-2031 ($ millions)
Figure 69. Russia Amebiasis Market Size 2026-2031 ($ millions)
Figure 70. Egypt Amebiasis Market Size 2026-2031 ($ millions)
Figure 71. South Africa Amebiasis Market Size 2026-2031 ($ millions)
Figure 72. Israel Amebiasis Market Size 2026-2031 ($ millions)
Figure 73. Turkey Amebiasis Market Size 2026-2031 ($ millions)
Figure 74. Global Amebiasis Market Size Market Share Forecast by Type (2026-2031)
Figure 75. Global Amebiasis Market Size Market Share Forecast by Application (2026-2031)
Figure 76. GCC Countries Amebiasis Market Size 2026-2031 ($ millions)